Literature DB >> 608688

Immunosuppression in murine malaria. II. The primary response to bovine serum albumin.

J S McBride, H S Micklem.   

Abstract

The primary antibody response to alumadsorbed bovine serum albumin was depressed in CBA mice infected with Plasmodium yoelii yoelii. Responses initiated within approximately 3 weeks of this malaria infection were reduced in quantity, but not in avidity. Responses initated later were normal. A depressed primary response was also seen in infected compared to control splenectomized mice; this was accompanied by impaired priming for a secondary response.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 608688      PMCID: PMC1445344     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  Exclusion chromatography.

Authors:  K O PEDERSEN
Journal:  Arch Biochem Biophys       Date:  1962-09       Impact factor: 4.013

2.  A quantitative immunochemical measure of the primary interaction between I BSA and antibody.

Authors:  R S FARR
Journal:  J Infect Dis       Date:  1958 Nov-Dec       Impact factor: 5.226

3.  Depression of immune response to Moloney leukaemia virus by malarial infection.

Authors:  R Bomford; N Wedderburn
Journal:  Nature       Date:  1973-04-13       Impact factor: 49.962

4.  The effect of malaria on the relative affinity of mouse antiprotein antibody.

Authors:  M W Steward; A Voller
Journal:  Br J Exp Pathol       Date:  1973-04

5.  The validity of the ammonium sulphate precipitation technique of estimation of antibody amount and avidity.

Authors:  S Ahlstedt; J Holmgren; L A Hanson
Journal:  Immunology       Date:  1973-12       Impact factor: 7.397

6.  The immunodepressive effect of a murine plasmodium and its interaction with murine oncogenic viruses.

Authors:  M H Salaman; N Wedderburn; L J Bruce-Chwatt
Journal:  J Gen Microbiol       Date:  1969-12

7.  Immunosuppression in murine malaria. I. General characteristics.

Authors:  B M Greenwood; J H Playfair; G Torrigiani
Journal:  Clin Exp Immunol       Date:  1971-03       Impact factor: 4.330

8.  A genetic investigation of virulence in a rodent malaria parasite.

Authors:  D Walliker; A Sanderson; M Yoeli; B J Hargreaves
Journal:  Parasitology       Date:  1976-04       Impact factor: 3.234

9.  Inhibition of the immune response to pertussis vaccine during Plasmodium berghei yoelii infection in mice.

Authors:  P Viens; A Tarzaali; M Quevillon
Journal:  Am J Trop Med Hyg       Date:  1974-09       Impact factor: 2.345

10.  Immunosuppression in murine malaria. I. Response to type III pneumococcal polysaccharide.

Authors:  J S McBride; H S Micklem; J M Ure
Journal:  Immunology       Date:  1977-05       Impact factor: 7.397

View more
  9 in total

1.  Effect of chronic Trypanosoma brucei infection on the course of louping ill virus infection in mice.

Authors:  H W Reid; D Buxton; J Finlayson; P H Holmes
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

2.  Reduced antibody response to the repetitive sequence of the Plasmodium falciparum circumsporozoite protein in mice infected with Plasmodium yoelii blood forms.

Authors:  D Grillot; A Pessi; A S Verdini; P H Lambert; G Del Giudice
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

3.  Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial.

Authors:  Martina Oneko; Laura C Steinhardt; Reuben Yego; Ryan E Wiegand; Phillip A Swanson; Natasha Kc; Dorcas Akach; Tony Sang; Julie R Gutman; Elizabeth L Nzuu; Allan Dungani; B Kim Lee Sim; Paul Ndaya Oloo; Kephas Otieno; Dennis K Bii; Peter F Billingsley; Eric R James; Simon Kariuki; Aaron M Samuels; Said Jongo; Winnie Chebore; Salim Abdulla; Claudia Daubenberger; Maxmillian Mpina; David Styers; Gail E Potter; Ginnie Abarbanell; Thomas L Richie; Stephen L Hoffman; Robert A Seder
Journal:  Nat Med       Date:  2021-09-13       Impact factor: 53.440

4.  Immunosuppression in murine malaria. III. Induction of tolerance and of immunological memory by soluble bovine serum albumin.

Authors:  J Strambachovà-McBride; H S Micklem
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

5.  Immunodepression of thymus-independent response to dextran in mouse malaria.

Authors:  J S McBride; H S Micklem
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

6.  Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines.

Authors:  Jennifer B Rosen; Joel G Breman; Charles R Manclark; Bruce D Meade; William E Collins; Hans O Lobel; Pierre Saliou; Jacquelin M Roberts; Pierre Campaoré; Mark A Miller
Journal:  Malar J       Date:  2005-11-06       Impact factor: 2.979

Review 7.  Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function.

Authors:  Owain R Millington; Caterina Di Lorenzo; R Stephen Phillips; Paul Garside; James M Brewer
Journal:  J Biol       Date:  2006-04-12

Review 8.  Pathogenic Th1 responses in CHIKV-induced inflammation and their modulation upon Plasmodium parasites co-infection.

Authors:  Anthony Torres-Ruesta; Teck-Hui Teo; Yi-Hao Chan; Laurent Rénia; Lisa F P Ng
Journal:  Immunol Rev       Date:  2019-11-26       Impact factor: 12.988

9.  PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection.

Authors:  Sean C Murphy; Gregory A Deye; B Kim Lee Sim; Shirley Galbiati; Jessie K Kennedy; Kristen W Cohen; Sumana Chakravarty; Natasha Kc; Yonas Abebe; Eric R James; James G Kublin; Stephen L Hoffman; Thomas L Richie; Lisa A Jackson
Journal:  PLoS Pathog       Date:  2021-05-28       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.